8-bromo cyclic adenosine monophosphate has been researched along with Neuroectodermal Tumors, Primitive, Peripheral in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Davis, TP; Mania-Farnell, BL; Merrill, BJ; Yamamura, HI | 1 |
Davis, TP; Konings, PN; Mania-Farnell, BL; Merrill, BJ | 1 |
2 other study(ies) available for 8-bromo cyclic adenosine monophosphate and Neuroectodermal Tumors, Primitive, Peripheral
Article | Year |
---|---|
Second messenger activators regulate CCK mRNA in the human neuroepithelioma cell line SK-N-MCIXC.
Topics: 1-Methyl-3-isobutylxanthine; 8-Bromo Cyclic Adenosine Monophosphate; Cell Line; Cholecystokinin; Exons; Gene Expression; Humans; Neuroectodermal Tumors, Primitive, Peripheral; Restriction Mapping; RNA, Messenger; Second Messenger Systems; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1994 |
Regulation of CCK mRNA in the human neuroepithelioma cell line SK-N-MCIXC in response to second messenger activators.
Topics: 1-Methyl-3-isobutylxanthine; 8-Bromo Cyclic Adenosine Monophosphate; Cell Line; Cholecystokinin; Cyclic AMP; Dimethyl Sulfoxide; Gene Expression Regulation; Humans; Kinetics; Neuroectodermal Tumors, Primitive, Peripheral; Protein Kinase C; RNA, Messenger; Second Messenger Systems; Tetradecanoylphorbol Acetate | 1993 |